bluebird bio
BLUE
$0.90
Share price
-0.66%
Change (1 day)
-78.08%
Change (1 year)
bluebird bio (BLUE) - Total assets
Total assets on the balance sheet as of September 2023 : $0.61 B
According to bluebird bio 's latest financial reports the company's total assets are $0.61 B. A company’s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.
bluebird bio - Total assets on balance sheet (from 2012 to 2023)
Total assets by year
| Year | Total assets | Change |
|---|---|---|
| 2022-12-31 | $0.55 B | -6.55% |
| 2021-12-31 | $0.59 B | -66.66% |
| 2020-12-31 | $1.78 B | 3.12% |
| 2019-12-31 | $1.72 B | -22.98% |
| 2018-12-31 | $2.24 B | 18.01% |
| 2017-12-31 | $1.90 B | 69.98% |
| 2016-12-31 | $1.11 B | 11.55% |
| 2015-12-31 | $1.00 B | 80.04% |
| 2014-12-31 | $0.55 B | 148.11% |
| 2013-12-31 | $0.22 B | 223.69% |
| 2012-12-31 | $69.32 M | 124.21% |
| 2011-12-31 | $30.91 M |
Total Assets for similar companies or competitors
| Company | Total assets | differencediff. | Country |
|---|---|---|---|
 Sanofi SNY | $139.81 B | 22,685.88% | 🇫🇷 France |
 Merck MRK | $106.67 B | 17,284.88% | 🇺🇸 USA |
 Sangamo Therapeutics
SGMO | $0.16 B | -73.06% | 🇺🇸 USA |
 Acceleron Pharma XLRN | N/A | N/A | 🇺🇸 USA |
 GlycoMimetics
GLYC | $45.31 M | -92.61% | 🇺🇸 USA |
 BioMarin Pharmaceutical BMRN | $6.84 B | 1,014.98% | 🇺🇸 USA |